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In This IssueIn Review: Clinical-Grade iPS Cells
PAGE 1311
Generation of clinical grade iPS (CGiPS) cells provides paradigm-shifting therapeutic prospects. Through a critical
overview of available reprogramming protocols and cell source recipes, Wu et al. suggest that the innovative small
molecules developed for optimal cell sources can generate CGiPS cells.In Brief: Hitting Mitochondrial DNA with a
Cisplatin Analog
PAGE 1323
Wisnovsky et al. use a peptide specifically targeting mitochondria
to deliver an analog of cisplatin (mtPt) to this organelle in human
cells. mtPt induces apoptosis without damaging nuclear DNA,
indicating that mtDNA damage is sufficient to mediate the activity
of a platinum-based chemotherapeutic.Reduction in Global Histone Methylation
Gets to Lymphoma Cells
PAGE 1329
Garapaty-Rao et al. report discovery and optimization of the histone
lysine methyltransferases EZH2 and EZH1 inhibitor. The inhibitor
reduces global histone H3K27 di- and trimethylation, induces specific
transcriptional programs, and selectively kills lymphoma cells in a
dose- and time-dependent manner.Engineering Natural Product Biosynthesis through Docking Domains
PAGE 1340
Docking domains transfer intermediates between modules of type I polyketide synthases in the biosynthesis of
many medically relevant compounds and are targets for bioengineering to produce novel small molecules.
Whicher et al. identify a Class 2 docking domain and show it is an effective bioengineering tool.Chemistry & BiologyPhenotypic Screening for Specific
Inhibitors
PAGE 1352
For those using phenotypic screening for drug dis-
covery, target identification and mechanism of action
remain a challenge. Matheny et al. employ sequential
unbiased phenotypic small-molecule screens and
ultracomplex shRNA library screens to identify a class
of highly specific NAMPT inhibitors.20, November 21, 2013 ª2013 Elsevier Ltd All rights reserved v
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PAGE 1364
Winkler et al. explore the therapeutic value of combined PI3K-d and PI3K-g blockade and describe a potent oral
PI3K-d and PI3K-g inhibitor, IPI-145. IPI-145 showed potent activity in collagen-induced arthritis, ovalbumin-induced
asthma, and systemic lupus erythematosus rodent models.Resveratrol Derivative Binds Sirt3 in an
Unexpected Place
PAGE 1375
Resveratrol activates the human protein deacetylase Sirt1 and inhibits
Sirt3 through unknown mechanisms. Nguyen et al. describe a resveratrol
derivative that shows increased potency and inhibits both Sirt1 and Sirt3.
Structural work reveals that Sirt3 has a novel binding site for competitive
inhibition.Nucleotide Pyrophosphatases with a Taste for
Modified Nucleotides
PAGE 1386
Tchigvintsev et al. show that Maf proteins are a family of nucleotide pyro-
phosphatases active against both canonical and modified nucleotides. This
suggests that Mafs might have a dual role in cell division and in the preven-
tion of the incorporation of modified nucleotides into cellular nucleic acids.Cancer Cells with Supernumerary Centrosomes Beware!
PAGE 1399
Inhibition of HSET provides a unique opportunity to selectively target malignant cells with supernumerary centrosomes.
Watts et al. develop an allosteric HSET inhibitor that does not disrupt bipolar division in normal cells but leads to
multipolar mitoses in cancer cells with extra centrosomes, causing apoptosis.vi Chemistry & Biology 20, November 21, 2013 ª2013 ElseHexameric Histidine Kinase in Gas Phase
PAGE 1411
Wojnowska et al. use ion-mobility mass spectrometry to
demonstrate exchange between two conformational populations
of hexameric histidine kinase ExsG. The ‘‘open’’ and ‘‘closed/
compact’’ conformations correlate to the kinase activity and are
under phosphorylation-dependent regulation.Resources: Tracking Palmitoylation
Change in HD Brain
PAGE 1421
Protein palmitoylation is a reversible lipidation that regulates
tethering of many signaling proteins to membranes. Dysregulated
palmitoylation is linked to a variety of neurological disorders and
cancer. Wan et al. use proteomics to track brain palmitoylation
change induced in a mouse Huntington disease model.vier Ltd All rights reserved
